Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers

被引：0
|
作者：
Ricardo Ribas
Zara Ghazoui
Qiong Gao
Sunil Pancholi
Aradhana Rani
Anita Dunbier
Mitch Dowsett
Lesley-Ann Martin
机构：
[1] Breakthrough Breast Cancer Research Centre,Academic Department of Biochemistry
[2] Institute of Cancer Research,Department of Biochemistry
[3] Royal Marsden Hospital,undefined
[4] AstraZeneca,undefined
[5] Otago University,undefined
来源：
Breast Cancer Research | / 16卷
关键词：
Breast Cancer; Fulvestrant; CXCR7 Expression; Endocrine Resistance; Express Oestrogen Receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue
    Pedersen, SB
    Hansen, PS
    Lund, S
    Andersen, PH
    Odgaard, A
    Richelsen, B
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (04) : 262 - 269
  • [22] A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women
    Murray, J.
    Young, O. E.
    Renshaw, L.
    White, S.
    Williams, L.
    Evans, D. B.
    Thomas, J. St. J.
    Dowsett, M.
    Dixon, J. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 495 - 501
  • [23] Selective oestrogen receptor modulators, aromatase inhibitors and the female breast
    Howell, A
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2005, 17 (04) : 429 - 434
  • [24] The oestrogen receptor and its selective modulators in gynaecological and breast cancer
    Vergote, I
    Neven, P
    van Dam, P
    Serreyn, R
    De Prins, F
    De Sutter, P
    Albertyn, G
    EUROPEAN JOURNAL OF CANCER, 2000, 36 : S1 - S9
  • [25] Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients
    Jordan, V. Craig
    Lewis-Wambi, Joan
    Kim, Helen
    Cunliffe, Heather
    Ariazi, Eric
    Sharma, Catherine G. N.
    Shupp, Heather A.
    Swaby, Ramona
    BREAST, 2007, 16 : S105 - S113
  • [26] Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer
    Jody Hazlett
    Virginia Niemi
    Aziz Aiderus
    Katelyn Powell
    Lyn Wise
    Roslyn Kemp
    Anita K. Dunbier
    Breast Cancer Research, 23
  • [27] Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer
    Hazlett, Jody
    Niemi, Virginia
    Aiderus, Aziz
    Powell, Katelyn
    Wise, Lyn
    Kemp, Roslyn
    Dunbier, Anita K.
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [28] Vandetanib to Overcome Endocrine Resistance in Estrogen Receptor Positive Breast Cancer
    Kakati, Rasha
    Whitman, Austin A.
    Kim, Hyunsoo
    Molina, Sarahi G.
    Beltran, Adriana S.
    Spanheimer, Philip M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S6 - S7
  • [29] Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
    De Marchi, Tommaso
    Foekens, John A.
    Umar, Arzu
    Martens, John W. M.
    DRUG DISCOVERY TODAY, 2016, 21 (07) : 1181 - 1188
  • [30] Mechanisms of endocrine resistance in hormone receptor-positive breast cancer
    Gao, Yuan
    Yu, Yang
    Zhang, Mingqing
    Yu, Wenjun
    Kang, Lihua
    FRONTIERS IN ONCOLOGY, 2024, 14
12345